• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Obesity (Silver Spring) Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients Who Are Overweight

tetano

Editor, Senior Moderator
Obesity (Silver Spring)


. 2020 May 19.
doi: 10.1002/oby.22907. Online ahead of print.
Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients Who Are Overweight


Andrew Higham[SUP] 1 [/SUP], Dave Singh[SUP] 1 2 [/SUP]



Affiliations

Abstract

Objective: Mortality from coronavirus disease 2019 (COVID-19) is increased in COPD patients. Furthermore, higher body mass index (BMI) is related to severe disease. SARS-CoV-2 utilises angiotensin converting enzyme 2 (ACE2) to gain cellular entry.
Methods: We have investigated whether ACE2 bronchial epithelial expression is increased in COPD patients who are overweight compared to those who are not by RNA sequencing.
Results: We observed increased ACE2 expression in COPD patients who are overweight (mean BMI 29 kg/m[SUP]2[/SUP] ) compared to those notoverweight (mean BMI 21 kg/m[SUP]2[/SUP] ) (p=0.004).
Conclusion: Increased ACE2 expression may cause increased SARS-CoV-2 infection of the respiratory tract. COPD patients who are overweight may be at greater risk of developing severe COVID-19.

Keywords: ACE2; Bronchial Epithelium; COPD; COVID-19; Coronavirus; Obesity.
 
Back
Top Bottom